-
Advancing ADC Linker and Antibody Conjugation Technology for the Development of Homogenous Antibody Drug Conjugates
Jun , 25 2024
Rising interest in ADC linker and antibody conjugation technology for the development of homogenous antibody drug conjugates (ADCs) is driven by the need for targeted cancer therapies with improved sa...
read more